|
TSN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.61330000154103E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.44519992931691E-10 |
| Normal-vs-Stage2 |
4.560800E-03 |
| Normal-vs-Stage3 |
3.879000E-01 |
| Normal-vs-Stage4 |
4.708600E-01 |
| Stage1-vs-Stage2 |
2.617200E-01 |
| Stage1-vs-Stage3 |
1.332050E-02 |
| Stage1-vs-Stage4 |
2.669700E-02 |
| Stage2-vs-Stage3 |
1.950020E-01 |
| Stage2-vs-Stage4 |
2.742800E-01 |
| Stage3-vs-Stage4 |
9.415000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.56679999477427E-08 |
| Normal-vs-AfricanAmerican |
1.006500E-04 |
| Normal-vs-Asian |
5.849600E-01 |
| Caucasian-vs-AfricanAmerican |
3.894200E-01 |
| Caucasian-vs-Asian |
2.813600E-01 |
| AfricanAmerican-vs-Asian |
4.526400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.54860038523464E-10 |
| Normal-vs-Female |
1.353820E-01 |
| Male-vs-Female |
1.76365999999817E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.59049999999672E-05 |
| Normal-vs-Extreme_Weight |
3.5161995537436E-10 |
| Normal-vs-Obese |
1.620140E-02 |
| Normal-vs-Extreme_Obese |
4.281500E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.275040E-01 |
| Normal_Weight-vs-Obese |
1.918820E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.933200E-01 |
| Extreme_Weight-vs-Obese |
5.341800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.727800E-01 |
| Obese-vs-Extreme_Obese |
1.379010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.262600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.97779999999903E-05 |
| Normal-vs-Age(61-80Yrs) |
1.0877999612191E-09 |
| Normal-vs-Age(81-100Yrs) |
6.192000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.587800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.975720E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.579800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.295600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.526200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.003400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.16459969340599E-10 |
| Normal-VS-Type2 PRCC |
5.042000E-03 |
| Normal-VS-KIRP CIMP |
3.064200E-01 |
| Normal-VS-Unclassified PRCC |
1.620460E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.055930E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.237940E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.100790E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.655550E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.263000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.177400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58912000000067E-05 |
| Normal-vs-N1 |
7.085000E-01 |
| Normal-vs-N2 |
8.022200E-01 |
| N0-vs-N1 |
1.421520E-03 |
| N0-vs-N2 |
6.586300E-02 |
| N1-vs-N2 |
8.762000E-01 |
|
|
